Back

Apellis Pharmaceuticals Stock Predictions

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.

Sell

APLS
Apellis Pharmaceuticals

Last Price:

36.70

Seasonality Move:

15.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market

Apellis Pharmaceuticals Stock Forecast

Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 23.3% based on the past 6 years of stock performance.
Apellis Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Apellis Pharmaceuticals Stock Undervalued?
The current Apellis Pharmaceuticals [APLS] share price is $36.73. The Score for APLS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Apellis Pharmaceuticals Stock Go Up Next Year?

Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 23.3% based on the past 6 years of stock performance.

Apellis Pharmaceuticals Stock Rating

Sell

Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals overpriced?

Apellis Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Apellis Pharmaceuticals Stock Price History

Is APLS stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

apellis.com

52-Week Data

52-Week High:

73.80

52-Week Low:

33.49

Prediction Charts

Market Cap:

4.47B

Price in USD:

36.73

Volume:

1.74M

Beta:

0.85

Technical Analysis

SMA50:

38.01

SMA100:

39.61

SMA200:

50.16

52-Wk Change:

-23.95%

Stock Predictions

Is Apellis Pharmaceuticals stock public?
Yes, Apellis Pharmaceuticals is a publicly traded company.
What is the Apellis Pharmaceuticals stock quote today?
The Apellis Pharmaceuticals stock price is 36.73 USD today.
How to buy Apellis Pharmaceuticals stock online?
You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Aug-30	38.72	38.87	39.29	38.43
Sep-3	38.36	38.79	40.35	38.18
Sep-4	38.60	37.78	39.14	37.52
Sep-5	37.77	39.29	39.34	37.45
Sep-6	39.67	41.05	41.64	39.38
Sep-9	41.05	39.98	41.94	39.20
Sep-10	40.16	39.18	40.67	38.80
Sep-11	38.97	38.36	39.51	38.10
Sep-12	38.07	36.80	38.69	36.57
Sep-13	36.29	37.62	38.55	36.29
Sep-16	37.50	36.31	37.55	35.52
Sep-17	36.48	35.53	36.93	35.16
Sep-18	35.79	35.64	37.06	35.49
Sep-19	36.24	36.73	37.84	36.10

Apellis Pharmaceuticals Earnings

Apellis Pharmaceuticals Earnings Report: Per Share Apellis Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Apellis Pharmaceuticals Forecast Revenue Growth

Apellis Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.24 per share, an increase this year of $3.17 per share, and an increase next year of $1.50 per share.

* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.